Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy

SIMPLE SUMMARY: Treatment of pregnant cancer patients should adhere as much as possible to standard treatment protocols in order to safeguard maternal prognosis. The use of Granulocyte colony-stimulating factor (G-CSF) can be indicated for dose dense chemotherapy in high risk breast cancer patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Berends, Claudia, Maggen, Charlotte, Lok, Christianne A. R., van Gerwen, Mathilde, Boere, Ingrid A., Wolters, Vera E. R. A., Van Calsteren, Kristel, Segers, Heidi, van den Heuvel-Eibrink, Marry M., Painter, Rebecca C., Gziri, Mina Mhallem, Amant, Frédéric
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001066/
https://ncbi.nlm.nih.gov/pubmed/33802196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061214
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars